Join
Live feed
·
INSIDERFilingvia Quantisnow
Oncocyte Corporation logo

Director Arno Andrew bought $26,350 worth of shares (12,500 units at $2.11), increasing direct ownership by 18% to 81,554 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OCX (Oncocyte Corporation) and more on Quantisnow.